[Effect of benziodarone and benzbromarone on the uric acid level in the blood and urine and on the incidence of gout attacks].
D000328:Adult; D000368:Aged; D001553:Benzbromarone / Q000627:therapeutic use*; D001572:Benzofurans / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006073:Gout / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D014527:Uric Acid / Q000037:antagonists & inhibitors / Q000378:metabolism*
D001572:Benzofurans; D014527:Uric Acid; D001553:Benzbromarone; C058702:benziodarone
Wpływ benziodaronu i benzbromaronu na poziom kwasu moczowego w surowicy i w moczu oraz na czestotliwość ataków dny.